2min chapter

The Top Line cover image

What to expect from the biotech IPO market in 2025

The Top Line

CHAPTER

Trends and Developments in Biotech IPOs: A 2024 Overview

This chapter explores the revitalization of the biotech IPO market in 2024, emphasizing the rise in company quality and a focus on key therapeutic areas. It also discusses enhancements in price discovery and investor engagement that contribute to improved valuation outcomes during IPO roadshows.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode